Industrial Applications of Whole-Cell Biocatalysis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industrial Applications of Whole-Cell Biocatalysis
Recombinant microbial whole-cell biocatalysis is a valuable approach for producing enantiomerically pure interemediates. The authors examine several groups of enzymes using this approach: dehydrogenases, hydantoinases, and acylases.


Pharmaceutical Technology


7. F. Cecere et al., "D-Carbamylamino Acids and Corresponding D-Amino Acids," Ger. Offen, 2,621, 076, Addn. to Ger. Offen. 2,422,737, Dec. 1976.

8. M. Kato, H. Kitagawa, and T. Miyoshi, "Microbial Racemization of Optically Active 5-Substituted Hydantions," Japanese Patent 62122591, 1987.

9. M. Pietzsch, C. Syldatk, and F. Wagner, "Isolation and Characterization of a New, Nonpyrioxal-5'-Phosphate Dependent Hydantion Racemase," DECHEMA Biotechnol. Conf. 4 (Pt A. Lect), 259–262 (1990).

10. C. Syldatk et al., "Microbial Hydantoinases—Industrial Enzymes from the Origin of Life?," Appl. Microbiol. Biotechnol. 51 (3), 293–309 (1999).

11. C. Gross, C. Syldatk, and F. Wagner, "Screening Method for Microorganisms Producing L-Amino Acids from D,L-5-Monosubstituted Hydantoins," Biotechnol. Tech. 1 (2) 85–90 (1987).

12. Y. Nishida et al., "Enzymatic Production of L-tryptophan from D,L-5-Indolylmethylhydantoin by Flavobacterium sp.," Enzyme Microb. Technol. 9 (12), 721–725 (1987).

13. D. Cotoras and F. Wagner, "Stereospecific Hydrolysis of 5-Monosubstituted Hydantoins," 3rd Eur. Congr. Biotechnol. 1, 351–356 (1984).

14. F. Wagner et al., "Microorganisms Producing L- Amino Acids, " German Patent DE 19519717, 1996

15. T. Wagner, B. Hantke, and F.J. Wagner, "Production of L-methionine from D,L-5-(2-methylthioethyl) Hydantoin by Resting Cells of a New Mutant Strain of Arthrobacter species DSM 7330," J. Biotechnol. 46 (1), 63–68 (1996).

16. O. May et al., "Substrate-Dependent Enantioselectivity of a Novel Hydantoinase from Arthrobacter aurescens DSM 3745: Purification and Characterization as New Member of Cyclic Amidases," J. Biotechnol. 61 (1) 1–13 (1998).

17. D. Volkel and F. Wagner, "Reaction Mechanism for the Conversion of 5-Monosubstituted Hydantoins to Enantiomerically Pure L-Amino Acids," Ann. N.Y. Acad. Sci., 750, 1–9 (1995).

18. O. May, P.T. Nguyen, and F.H. Arnold, "Inverting Enantioselectivity by Directed Evolution of Hydantoinase for Improved Production of L-Methionine," Nat. Biotechnol. 18 (3), 317–320 (2000).

19. A.S. Bommarius et al., "Operational Stability of Enzymes. Acylase-Catalyzed Resolution of N-Acetyl Amino Acids to Enantiomerically Pure L-Amino Acids," Ann. N. Y. Acad. Sci. 672, 126–136 (1992).

20. A.S. Bommarius, M. Schwarm, and K. Drauz, "The Membrane Reactor for the Acylase Process—From Laboratory Results to Commercial Scale," Chimica Oggi. 14 (10), 61–64 (1996).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here